ArticlePharmacoEconomics2025

Surrogate Outcomes Used as Proxies in Rare Long-Term Conditions: Evidence Assessment Group Perspective.

Eugenie Evelynne Johnson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.